Trinity Biotech PLC Share Price Today: Live Updates & Key Insights
Trinity Biotech PLC share price today is $0.64, up -2.27%. The stock opened at $0.65655 against the previous close of $0.6515, with an intraday high of $0.6709 and low of $0.64.
Trinity Biotech PLC Share Price Chart
Trinity Biotech PLC
Trinity Biotech PLC Share Price Performance
Trinity Biotech PLC Institutional Holdings
Trinity Biotech PLC Market Status
Trinity Biotech PLC Fundamentals
Market Cap 15.89 M
PB Ratio 5.1132
PE Ratio 0.0
Enterprise Value 123.11 M
Total Assets 103.29 M
Volume 106058
Trinity Biotech PLC Company Financials
About Trinity Biotech PLC & investment objective
Company Information Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. In addition, the company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc It has a collaboration agreement with a bioinformatics company to conduct analysis on clinical trial data for EpiCapture, a PCR-based epigenetic liquid biopsy test for monitoring the risk of prostate cancer progressing to aggressive forms of the disease. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.
Organisation Medical Devices
Employees 401
Industry Medical Devices
CEO Mr. John Gillard
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Trinity Biotech PLC FAQs
What is the share price of Trinity Biotech PLC today?
The current share price of Trinity Biotech PLC is $0.64.
Can I buy Trinity Biotech PLC shares in India?
Yes, Indian investors can buy Trinity Biotech PLC shares by opening an international trading and demat account with Motilal Oswal.
How to buy Trinity Biotech PLC shares in India?
You can easily invest in Trinity Biotech PLC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Trinity Biotech PLC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Trinity Biotech PLC.
Can I buy fractional shares of Trinity Biotech PLC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Trinity Biotech PLC?
Trinity Biotech PLC has a market cap of $15.89 M.
In which sector does Trinity Biotech PLC belong?
Trinity Biotech PLC operates in the Medical Devices sector.
What documents are required to invest in Trinity Biotech PLC stocks?
To invest, you typically need:
What is the PE and PB ratio of Trinity Biotech PLC?
The PE ratio of Trinity Biotech PLC is N/A and the PB ratio is 5.11.